A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia

Mise à jour : Il y a 4 ans
Référence : NCT00002154

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to see if it is safe and effective to give thioctic acid and deprenyl (selegiline hydrochloride), alone or in combination, to HIV-infected patients who have mild to moderate dementia (a decline in their mental abilities).


Critère d'inclusion

  • Cognitive Disorders,HIV Infections

Liens